Hypertension--current management: part II.
D001521:Behavior Therapy; D001676:Biofeedback, Psychology; D004232:Diuretics / Q000627:therapeutic use; D004338:Drug Combinations; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000178:diet therapy / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D007263:Infusions, Parenteral; D008750:Methyldopa / Q000627:therapeutic use; D005082:Physical Exertion; D013565:Sympatholytics / Q000627:therapeutic use; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use; D000092502:Renin Inhibitors
D004232:Diuretics; D004338:Drug Combinations; D006145:Guanethidine; D008750:Methyldopa; D013565:Sympatholytics; D014665:Vasodilator Agents; D000092502:Renin Inhibitors